Group Product Director, Professional Promotion, Neuroscience Schizophrenia

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.  We provide an inclusive work environment where each person is considered as an individual.  At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit. Job Function: Marketing Job Sub Function: Product Management Job Category: People Leader All Job Posting Locations: Titusville, New Jersey, United States of America Job Description: Johnson & Johnson is recruiting for a Group Product Director (GPD), Professional Promotion, Neuroscience Schizophrenia located in Titusville, NJ. About Neuroscience Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Neuroscience team tackles the world’s toughest brain health challenges including multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, myasthenia gravis, epilepsy, major depressive disorder, bipolar disorder, schizophrenia, and autism. This patient-focused team helps address some of the most complex diseases of our time. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine Role Overview The Group Product Director (GPD), Professional Promotion, Neuroscience Schizophrenia will lead the U.S. HCP marketing strategy and professional education across the long-acting injectable portfolio, comprised of INVEGA SUSTENNA®, INVEGA TRINZA®, and INVEGA HAFYERA®. This leader will also partner closely with the CAPLYTA® brand team to deliver a cohesive schizophrenia portfolio strategy. The role requires strong strategic leadership, disciplined execution, cross-functional influence, and the ability to coach and develop a high-performing team of marketers. This Group Product Director will report to the Director of Marketing, Neuroscience Schizophrenia.

Coach and develop a high-performing team while fostering an inclusive culture and strengthening marketing capabilities. Shape and execute U.S. HCP marketing strategies, professional education priorities, and omnichannel initiatives to enhance customer engagement and maximize brand performance. Champion data-driven decision making and proactively adjust strategy using market research, analytics, and field insights. Lead and advance Key Opinion Leader (KOL) engagement strategy to inform customer insights and support professional education priorities. Continuously advance core marketing fundamentals, including insight generation, segmentation, co-positioning, message and creative development, and impact measurement. Partner closely with the CAPLYTA® brand team to develop and execute a cohesive schizophrenia portfolio strategy with clear alignment across priorities, messaging, and field execution. Manage the agency-of-record relationship and other agency/vendor partners to deliver high-quality HCP tactics on strategy, on time, and within budget. Partner closely with Sales leadership to ensure seamless execution, field readiness, pull-through, and feedback loops that improve customer engagement and business impact. Optimize resource allocation and investment decisions to maximize performance and return on investment. Build strong partnerships